Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kura Oncology (KURA) Operating Expenses (2023 - 2024)

Kura Oncology (KURA) has disclosed Operating Expenses for 2 consecutive years, with $76.3 million as the latest value for Q4 2024.

  • Quarterly Operating Expenses rose 63.25% to $76.3 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $76.3 million through Sep 2025, down 64.9% year-over-year, with the annual reading at $371.1 million for FY2025, 50.2% up from the prior year.
  • Operating Expenses for Q4 2024 was $76.3 million at Kura Oncology, up from $59.9 million in the prior quarter.
  • The five-year high for Operating Expenses was $76.3 million in Q4 2024, with the low at $36.6 million in Q1 2023.